The regulation and physiological roles of the guanylyl cyclase receptors

Endocrine Journal

Volumn 48, Issue 6, 2001, Pages 611-634

  Tamura, N ^a   Chrisman, T D ^a   Garbers, D L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Cyclic GMP; Gene disruption; Guanylyl cyclase; Natriuretic peptide; Receptor signaling

Indexed keywords

CYCLIC GMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASE; GUANYLATE CYCLASE; GUANYLYL CYCLASE A; GUANYLYL CYCLASE B; GUANYLYL CYCLASE C; GUANYLYL CYCLASE D; GUANYLYL CYCLASE E; GUANYLYL CYCLASE F; GUANYLYL CYCLASE G; GUANYLYL CYCLASE RECEPTOR; ISOENZYME; NATRIURETIC FACTOR; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; CHROMOSOMAL LOCALIZATION; DISULFIDE BOND; ENZYME ACTIVITY; ENZYME ANALYSIS; GENE DELETION; GENE DISRUPTION; GENE EXPRESSION REGULATION; GENE ORDER; GENE OVEREXPRESSION; GENE STRUCTURE; GENETIC MODEL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN PROCESSING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0035679709     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.48.611     Document Type: Review

References (206)

1. Isolation of adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate from rat urine
2. The formation and metabolism of cyclic GMP
3. The effect of cyclic adenosine- and guanosine 3′,5′-monophosphate on the normal and drug-increased coronary blood flow
4. Magnitude of increase in retinal cGMP metabolic flux determined by 180 incorporation into nucleotide alpha-phosphoryls corresponds with intensity of photic stimulation
5. Cyclic nucleotide phosphodiesterases: Relating structure and function
6. Hormone-induced cyclic guanosine monophosphate secretion from guinea pig pancreatic lobules
7. Cyclic GMP efflux from liver slices
8. Atrial natriuretic factor-induced egression of cyclic guanosine 3′,5′-monophosphate in cultured vascular smooth muscle and endothelial cells
9. Desensitization of atriopeptin stimulated accumulation and extrusion of cyclic GMP from a kidney epithelial cell line (MDCK)
10. Association between synthesis and release of cGMP and nitric oxide biosynthesis by hepatocytes
11. Secretion of cyclic GMP by cultured epithelial and fibroblast cell lines in response to nitric oxide
12. Export of guanosine 3′,5′-cyclic monophosphate (cGMP) from human erythrocytes characterized by inside-out membrane vesicles
13. The multidrug resistance protein 5 functions as an ATPdependent export pump for cyclic nucleotides
14. Intracellular cyclic GMP receptor proteins
15. Rising behind NO: cGMP-dependent protein kinases
16. 2+ in sea urchin eggs by stimulating cyclic ADPribose synthesis
17. The primary structure of a plasma membrane guanylate cyclase demonstrates diversity within this new receptor family
18. Guanylyl cyclase receptors
19. Guanylyl cyclase is a heat-stable enterotoxin receptor
20. A membrane form of guanylate cyclase is an atrial natriuretic peptide receptor
21. Selective activation of the B natriuretic peptide receptor by Ctype natriuretic peptide (CNP)
22. Atrial natriuretic peptide clearance receptor. Complete sequence and functional expression of cDNA clones
23. Structure of the bovine atrial natriuretic peptide receptor (type C) gene
24. Physiological role of silent receptors of atrial natriuretic factor
25. Purification and subunit composition of atrial natriuretic peptide receptor
26. Purification of atrial natriuretic peptide receptor from bovine lung. Evidence for a disulfide-linked subunit structure
27. Cytoplasmic domain of natriuretic peptide receptor-C inhibits adenylyl cyclase. Involvement of a pertussis toxin-sensitive G protein
28. Guanylin: An endogenous activator of intestinal guanylate cyclase
29. Uroguanylin: Structure and activity of a second endogenous peptide that stimulates intestinal guanylate cyclase
30. Lymphoguanylin: Cloning and characterization of a unique member of the guanylin peptide family
31. Cloning, properties, site-directed mutagenesis analysis of the subunit structure, tissue distribution and regulation of expression of the type-C eel natriuretic peptide receptor
32. Characterization of the hormone binding site of natriuretic peptide receptorC
33. Structure of the dimerized hormone-binding domain of a guanylyl-cyclase-coupled receptor
34. Disulfide bond structure of the atrial natriuretic peptide receptor extracellular domain: Conserved disulfide bonds among guanylate cyclase-coupled receptors
35. Human natriuretic peptide receptor-A guanylyl cyclase. Hormone crosslinking and antibody reactivity distinguish receptor glycoforms
36. Guanylyl cyclase C is an N-linked glycoprotein receptor that accounts for multiple heat-stable enterotoxin-binding proteins in the intestine
37. Bacterial periplasmic permeases belong to a family of transport proteins operating from Escherichia coli to human: Traffic ATPases
38. The ligand-binding domain in metabotropic glutamate receptors is related to bacterial periplasmic binding proteins
39. Guanylyl cyclases: Approaching year thirty
40. Atrial natriuretic factor binding to its receptor is dependent on chloride concentration: A possible feedback -control mechanism in renal salt regulation
41. Modulation by NaCl of atrial natriuretic peptide receptor levels and cyclic GMP responsiveness to atrial natriuretic peptide of cultured vascular endothelial cells
42. Dietary salt extremes and renal function in rats: Effect of atrial natriuretic factor
43. The cloning and expression of a new guanylyl cyclase orphan receptor
44. The protein kinase domain of the ANP receptor is required for signaling
45. The glycine residue of ATP regulatory module in receptor guanylate cyclases that is essential in natriuretic factor signaling
46. The guanylyl cyclase-A receptor transduces an atrial natriuretic peptide/ATP activation signal in the absence of other proteins
47. Dominant negative mutations of the guanylyl cyclase-A receptor. Extracellular domain deletion and catalytic domain point mutations
48. A mutation of the atrial natriuretic peptide (guanylyl cyclase-A) receptor results in a constitutively hyperactive enzyme
49. Exchange of substrate and inhibitor specificities between adenylyl and guanylyl cyclases
50. Two amino acid substitutions convert a guanylyl cyclase. RetGC-1, into an adenylyl cyclase
51. Solubilization and characterization of functionally coupled Escherichia coli heat-stable toxin receptors and particulate guanylate cyclase associated with the cytoskeleton compartment of intestinal membranes
52. The significance of Ser1029 of the heat-stable enterotoxin receptor (STaR): Relation of STa-mediated guanylyl cyclase activation and signaling by phorbol myristate acetate
53. Studying the structure and regulation of soluble guanylyl cyclase
54. Soluble guanylate cyclase from rat lung exists as a heterodimer
55. A new form of guanylyl cyclase is preferentially expressed in rat kidney
56. Molecular cloning and expression of a new a-subunit of soluble guanylyl cyclase. Interchangeability of the a-subunits of the enzyme
57. Human soluble guanylate cyclase: Functional expression and revised isoenzyme family
58. Expression of soluble guanylate cyclase activity requires both enzyme subunits
59. Ligand-independent oligomerization of natriuretic peptide receptors. Identification of heteromeric receptors and a dominant negative mutant
60. Identification and characterization of a novel b subunit of soluble guanylyl cyclase that is active in the absence of a second subunit and is relatively insensitive to nitric oxide
61. Differential regional expression of three natriuretic peptide receptor genes within primate tissues
62. Human atrial natriuretic peptide receptor defines a new paradigm for second messenger signal transduction
63. Widespread co-localization of mRNAs encoding the guanylate cyclase-coupled natriuretic peptide receptors in rat tissues
64. Detection of mRNA encoding guanylate cyclase A/atrial natriuretic peptide receptor in the rat cochlea by competitive polymerase chain reaction and in situ hybridization
65. Phenotype-related alteration in expression of natriuretic peptide receptors in aortic smooth muscle cells
66. Peptide-regulated guanylate cyclase pathways in rat colon: In situ localization of GCA, GCC, and guanylin mRNA
67. Functional expression of components of the natriuretic peptide system in human ocular nonpigmented ciliary epithelial cells
68. Expression of guanylate cyclase-A mRNA in the rat retina: Detection using polymerase chain reaction
69. Natriuretic peptide receptors on rat thymocytes: Inhibition of proliferation by atrial natriuretic peptide
70. C-type natriuretic peptide and the guanylyl cyclase receptors in the rat ovary are modulated by the estrous cycle
71. Expression of biologically active receptors for natriuretic peptides in the human uterus during pregnancy
72. Cloning and characterization of two forms of C-type natriuretic peptide receptor in rat brain
73. Natriuretic peptide regulation of endochondral ossification. Evidence for possible roles of the C-type natriuretic peptide/guanylyl cyclase-B pathway
74. Guanylyl cyclase-B represents the predominant natriuretic peptide receptor expressed at exceptionally high levels in the pineal gland
75. Seminal plasma factors that cause large elevations in cellular cyclic GMP are C-type natriuretic peptides
76. Differential activation by atrial and brain natriuretic peptides of two different receptor guanylate cyclases
77. Signaling pathways for guanylin and uroguanylin in the digestive, renal, central nervous, reproductive, and lymphoid systems
78. Structure and activity of OK-GC: A kidney receptor guanylate cyclase activated by guanylin peptides
79. Guanylyl cyclase-C receptor mRNA distribution along the rat nephron
80. Upregulation of Escherichia coli heat-stable enterotoxin receptor in regenerating rat liver
81. Guanylyl cyclase C is a selective marker for metastatic colorectal tumors in human extraintestinal tissues
82. A receptor guanylyl cyclase expressed specifically in olfactory sensory neurons
83. Two membrane forms of guanylyl cyclase found in the eye
84. The primary structure of the larger subunit of soluble guanylyl cyclase from bovine lung. Homology between the two subunits of the enzyme
85. Molecular cloning and expression of cDNAs coding for soluble guanylate cyclase from rat lung
86. Tissue distribution of the human soluble guanylate cyclases
87. Differential expression of mRNA for guanylyl cyclase-linked endothelium-derived relaxing factor receptor subunits in rat kidney
88. Functional properties of a naturally occurring isoform of soluble guanylyl cyclase
89. The primary structure of the 70 kDa subunit of bovine soluble guanylate cyclase
90. Molecular cloning of a cDNA coding for 70 kilodalton subunit of soluble guanylate cyclase from rat lung
91. A variant of the a2 subunit of soluble guanylyl cyclase contains an insert homologous to a region within adenylyl cyclases and functions as a dominant negative protein
92. The b2 subunit of soluble guanylyl cyclase contains a human-specific frameshift and is expressed in gastric carcinoma
93. Guanylyl cyclases with the topology of mammalian adenylyl cyclases and an N-terminal P-type ATPase-like domain in Paramecium. Tetrahymena and Plasmodium
94. Guanylyl cyclase activity associated with putative bifunctional integral membrane proteins in Plasmodium falciparum
95. Chromosomal distribution of three members of the human natriuretic peptide receptor/guanylyl cyclase gene family
96. Localization of the guanylyl cyclase C gene to mouse chromosome 6 and human chromosome 12p12
97. Human retinal guanylate cyclase (GUC2D) maps to chromosome 17p13.1
98. Chromosomal localization and genomic organization of genes encoding guanylyl cyclase receptors expressed in olfactory sensory neurons and retina
99. Colocalization of the genes coding for the a3 and β3 subunits of soluble guanylyl cyclase to human chromosome 4 at q21-q33
100. Assignment of GUCIA2, the gene coding for the a2 subunit of soluble guanylyl cyclase, to position 11q14.3 on human chromosome 11
101. Assignment of GUCY1B2, the gene coding for the β2 subunit of human guanylyl cyclase to chromosomal band 13q14.3 between markers D13S168 and D13S155
102. Tandem organization of medaka fish soluble guanylyl cyclase al and βl subunit genes. Implications for coordinated transcription of two subunit genes
103. Genomic organization of α1 and β1 subunits of the mammalian soluble guanylyl cyclase genes
104. Genetic mapping of soluble guanylyl cyclase genes: Implications for linkage to blood pressure in the Dahl rat
105. The primary structure of the rat guanylyl cyclase A/atrial natriuretic peptide receptor gene
106. Organization of the human natriuretic peptide receptor A gene
107. Structure of the type B human natriuretic peptide receptor gene and association of a novel microsatellite polymorphism with essential hypertension
108. The bovine guanylate cyclase GC-E gene and 5′ flanking region
109. Hepatocyte nuclear factor-4 regulates intestinal expression of the guanylin/heat-stable toxin receptor
110. Structure of the 5′-flanking regulatory region of the mouse gene encoding the clearance receptor for atrial natriuretic peptide
111. Spl dependence of natriuretic peptide receptor A gene transcription in rat aortic smooth muscle cells
112. Atrial natriuretic peptide suppresses the transcription of its guanylyl cyclase-linked receptor
113. Intestinal apolipoprotein AI gene transcription is regulated by multiple distinct DNA elements and is synergistically activated by the orphan nuclear receptor, hepatocyte nuclear factor 4
114. Constitutive expression of murine complement factor B gene is regulated by the interaction of its upstream promoter with hepatocyte nuclear factor 4
115. Ligand-dependent regulation of NPR-A gene expression in inner medullary collecting duct cells
116. Altered expression of natriuretic peptide receptors in proANP gene disrupted mice
117. Regulation of natriuretic peptide receptor A and B expression by transforming growth factor-β1 in cultured aortic smooth muscle cells
118. Natriuretic peptide clearance receptor is transcriptionally down-regulated by β2-adrenergic stimulation in vascular smooth muscle cells
119. Ring-deleted analogs of atrial natriuretic factor inhibit adenylate cyclase/cAMP system. Possible coupling of clearance atrial natriuretic factor receptors to adenylate cyclase/cAMP signal transduction system
120. Downregulation of Creceptor by natriuretic peptides via ANP-B receptor in vascular smooth muscle cells
121. Mechanisms of tolerance to sodium nitroprusside in rat cultured aortic smooth muscle cells
122. Rapid desensitization of the nitric oxide receptor, soluble guanylyl cyclase, underlies diversity of cellular cGMP responses
123. Nitric oxide decreases stability of mRNAs encoding soluble guanylate cyclase subunits in rat pulmonary artery smooth muscle cells
124. Nerve growth factor decreases soluble guanylate cyclase in rat pheochromocytoma PC12 cells
125. Dephosphorylation of the guanylyl cyclase-A receptor causes desensitization
126. Phosphorylation-dependent regulation of the guanylyl cyclase-linked natriuretic peptide receptor B: Dephosphorylation is a mechanism of desensitization
127. Vasopressin-mediated inhibition of atrial natriuretic factor-stimulated cGMP accumulation in an established smooth muscle cell line
128. Angiotensin decreases cyclic GMP accumulation produced by atrial natriuretic factor
129. Endothelin inhibits the atrial natriuretic factor stimulated cGMP production by activating the protein kinase C in rat aortic smooth muscle cells
130. Endothelin-3 attenuates the cyclic GMP responses to C-type natriuretic peptide in cultured mouse astrocytes
131. Activation of protein kinase C stimulates the dephosphorylation of natriuretic peptide receptor-B at a single serine residue. A possible mechanism of heterologous desensitization
132. Dual regulation of heat-stable enterotoxin-mediated cGMP accumulation in T84 cells by receptor desensitization and increased phosphodiesterase activity
133. Homologous desensitization of the human guanylate cyclase C receptor. Cell-specific regulation of catalytic activity
134. Phosphorylation and activation of the intestinal guanylyl cyclase receptor for Escherichia coli heat-stable toxin by protein kinase C
135. Sub-second kinetics of the nitric oxide receptor, soluble guanylyl cyclase, in intact cerebellar cells
136. Targeting of a distinctive proteinserine phosphatase to the protein kinase-like domain of the atrial natriuretic peptide receptor
137. Regulation of the atrial natriuretic peptide receptor by heat shock protein 90 complexes
138. A transmembrane guanylyl cyclase (Daf- 11) and Hsp90 (Daf-21) regulate a common set of chemosensory behaviors in Caenorhabditis elegans
139. Guanylyl cyclase activating protein. A calcium-sensitive regulator of phototransduction
140. Molecular cloning and characterization of retinal photoreceptor guanylyl cyclase-activating protein
141. Cloning, sequencing, and expression of a 24-kDa Ca(2+)-binding protein activating photoreceptor guanylyl cyclase
142. Molecular characterization of a third member of the guanylyl cyclase-activating protein subfamily
143. Identification of a guanylyl cyclase-activating protein-binding site within the catalytic domain of retinal guanylyl cyclase 1
144. Regions in vertebrate photoreceptor guanylyl cyclase ROS-GC1 involved in Ca(2+)-dependent regulation by guanylyl cyclase-activating protein GCAP-1
145. Activation of retinal guanylyl cyclase-1 by Ca2+-binding proteins involves its dimerization
146. Dimerization of guanylyl cyclase-activating protein and a mechanism of photoreceptor guanylyl cyclase activation
147. A possible role of RGS9 in phototransduction. A bridge between the cGMP-phosphodiesterase system and the guanylyl cyclase system
148. RGS9, a GTPase accelerator for phototransduction
149. Slowed recovery of rod photoresponse in mice lacking the GTPase accelerating protein RGS9-1
150. Stoichiometric analysis of internalization, recycling, and redistribution of photoaffinity-labeled guanylate cyclase/atrial natriuretic factor receptors in cultured murine Leydig tumor cells
151. Functional domains and expression of truncated atrial natriuretic peptide receptor-A: The carboxyl-terminal regions direct the receptor internalization and sequestration in COS-7 cells
152. Expression and regulation of the cGMP-binding, cGMPspecific phosphodiesterase (PDE5) in human colonic epithelial cells: Role in the induction of cellular refractoriness to the heat-stable enterotoxin peptide
153. Internalization of E. coli ST mediated by guanylyl cyclase C in T84 human colon carcinoma cells
154. Reciprocal antagonism coordinates C-type natriuretic peptide and mitogen-signaling pathways in fibroblasts
155. Growth factors and cutaneous wound repair
156. Cytokine-induced Ctype natriuretic peptide (CNP) secretion from vascular endothelial cells: Evidence for CNP as a novel autocrine/paracrine regulator from endothelial cells
157. Signal transduction in atherosclerosis: Integration of cytokines and the eicosanoid network
158. Regulation of endothelial production of C-type natriuretic peptide in coculture with vascular smooth muscle cells. Role of the vascular natriuretic peptide system in vascular growth inhibition
159. C-type natriuretic peptide inhibits intimal thickening after vascular injury
160. Adenovirusmediated gene transfer of C-type natriuretic peptide causes G1 growth inhibition of cultured vascular smooth muscle cells
161. Local expression of C-type natriuretic peptide markedly suppresses neointimal formation in rat injured arteries through an autocrine/paracrine loop
162. Local adenovirusmediated transfer of C-type natriuretic peptide suppresses vascular remodeling in porcine coronary arteries in vivo
163. Regulation of endothelial production of C-type natriuretic peptide by interaction between endothelial cells and macrophages
164. Long-term nitroglycerin treatment: Effect on direct and endothelium-mediated large coronary artery dilation in conscious dogs
165. The β2 subunit inhibits stimulation of the α1/β1 form of soluble guanylyl cyclase by nitric oxide. Potential relevance to regulation of blood pressure
166. Importance of NO/EDRF for glomerular and tubular function: Studies in the isolated perfused rat kidney
167. Immunolocalization of soluble guanylyl cyclase subunits in rat kidney
168. Saltresistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptide
169. Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor A
170. Disruption of the guanylyl cyclase-C gene leads to a paradoxical phenotype of viable but heat-stable enterotoxin-resistant mice
171. Mice lacking the guanylyl cyclase C receptor are resistant to STa-induced intestinal secretion
172. Genetic decreases in atrial natriuretic peptide and salt-sensitive hypertension
173. Cardiac fibrosis in mice lacking brain natriuretic peptide
174. Dwarfism and early death in mice lacking Ctype natriuretic peptide
175. Hypotension in transgenic mice expressing atrial natriuretic factor fusion genes
176. Molecular cloning of the complementary DNA and gene that encode mouse brain natriuretic peptide and generation of transgenic mice that overexpress the brain natriuretic peptide gene
177. Natriuretic peptide receptor 1 expression influences blood pressures of mice in a dose-dependent manner
178. The heart communicates with the kidney exclusively through the guanylyl cyclase-A receptor: Acute handling of sodium and water in response to volume expansion
179. A genetic model defines the importance of the atrial natriuretic peptide receptor (guanylyl cyclase-A) in the regulation of kidney function
180. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride
181. High concentrations of a cGMP-stimulated phosphodiesterase mediate ANP-induced decreases in cAMP and steroidogenesis in adrenal glomerulosa cells
182. A genetic model provides evidence that the receptor for atrial natriuretic peptide (guanylyl cyclase-A) inhibits cardiac ventricular myocyte hypertrophy
183. Blood pressure and fluid-electrolyte balance in mice with reduced or absent ANP
184. Hypoxia reduces atrial natriuretic peptide clearance receptor gene expression in ANP knockout mice
185. Salt-sensitive hypertension in ANP knockout mice: Potential role of abnormal plasma renin activity
186. Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor
187. Kidney function in ANF-transgenic mice: Effect of blood volume expansion
188. Genetic models reveal that brain natriuretic peptide can signal through different tissue-specific receptormediated pathways
189. Skeletal overgrowth in transgenic mice that overexpress brain natriuretic peptide
190. Autocrine regulation of rat chondrocyte proliferation by natriuretic peptide C and its receptor, natriuretic peptide receptor-B
191. Intestinal secretory defects and dwarfism in mice lacking cGMP-dependent protein kinase II
192. The natriuretic peptide clearance receptor locally modulates the physiological effects of the natriuretic peptide system
193. Three new allelic mouse mutations that cause skeletal overgrowth involve the natriuretic peptide receptor C gene (Npr3)
194. Significance of vascular natriuretic peptide system in vascular remodeling in humans and its application to gene therapy
195. Membrane targeting of cGMP-dependent protein kinase is required for cystic fibrosis transmembrane conductance regulator Clchannel activation
196. Cystic fibrosis heterozygote resistance to cholera toxin in the cystic fibrosis mouse model
197. Mechanisms of guanylin action via cyclic GMP in the kidney
198. Diarrhoea caused by Escherichia coli
199. Disruption of a retinal guanylyl cyclase gene leads to cone-specific dystrophy and paradoxical rod behavior
200. Retinal-specific guanylate cyclase gene mutations in Leber's congenital amaurosis
201. Mutations in the retinal guanylate cyclase (RETGC-1) gene in dominant cone-rod dystrophy
202. A null mutation in the photoreceptor guanylate cyclase gene causes the retinal degeneration chicken phenotype
203. GCAP1 (Y99C) mutant is constitutively active in autosomal dominant cone dystrophy
204. A subset of olfactory neurons that selectively express cGMP-stimulated phosphodiesterase (PDE2) and guanylyl cyclase-D define a unique olfactory signal transduction pathway
205. A cGMP-signaling pathway in a subset of olfactory sensory neurons
206. Targeted deletion of a cyclic nucleotide-gated channel subunit (OCNC1): Biochemical and morphological consequences in adult mice